GlassScriptPhysician profile
Melissa Perlman
NPI 1245271386
$7,409.60
in general payments reported to CMS, 2019-2025
36 companies · $1,343 in 2025
The $1,343 reported for 2025 was more than what 90% of Foot Surgery providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $746 · 2020: $671 · 2021: $546 · 2022: $1,277 · 2023: $1,554 · 2024: $1,273 · 2025: $1,343.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,169.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,169.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $2,355.49 | 2019-2025 | Collagenase Santyl, Regranex, Grafix Pl |
| Organogenesis INC. | $1,235.89 | 2019-2025 | Apligraf, Puraply, Puraply Am |
| Integra Lifesciences Corporation | $706.57 | 2020-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Stryker Corporation | $576.04 | 2019-2025 | Infinity Adaptis, Prophecy |
| Aroa Biosurgery Incorporated | $358.07 | 2022-2025 | |
| Polynovo North America LLC | $295.25 | 2023-2025 | Novosorb Btm |
| Paratek Pharmaceuticals, INC. | $254.34 | 2020-2023 | Nuzyra |
| Horizon Therapeutics Plc | $158.98 | 2019-2022 | |
| Trice Medical, INC. | $158.84 | 2022-2025 | |
| Ibsa Pharma INC. | $144.68 | 2024 | Licart, Tirosint |
| Kerecis Limited | $137.49 | 2021-2025 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Derma Sciences, INC. | $132.41 | 2019 | |
| Biotissue Holdings INC. | $129.76 | 2019-2023 | |
| Heron Therapeutics, INC. | $72.47 | 2022 | |
| Abbvie INC. | $68.60 | 2021-2024 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $66.90 | 2024 | |
| Kci USA, INC. | $65.35 | 2019-2022 | |
| Hnm Stainless, LLC | $55.00 | 2023 | |
| Biocomposites INC | $53.02 | 2024 | |
| Nevro Corp. | $52.85 | 2021-2023 | Senza |
| Wright Medical Technology, INC. | $39.93 | 2020 | |
| Access Pro Medical, LLC | $30.04 | 2025 | Matriderm |
| Globus Medical, INC. | $28.58 | 2025 | Senza |
| Acera Surgical, INC. | $26.27 | 2022 | |
| Reprise Biomedical, INC. | $25.60 | 2024 | Miro3d |
| Orthofix Medical, INC. | $24.89 | 2022 | |
| Medtronic, INC. | $23.90 | 2023 | Intellis Adaptivestim |
| Philips North America LLC | $23.60 | 2021 | |
| Nabriva Therapeutics, Plc | $21.72 | 2022 | |
| Solventum Corporation | $17.80 | 2024 | Activ.A.C., Adaptic, V.A.C. Dermatac |
| Djo, LLC | $17.42 | 2020 | |
| Bioventus LLC | $13.96 | 2025 | Exogen Ultrasound Bone Healing System |
| Baxter Healthcare | $13.34 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $12.85 | 2022 | |
| Acell, INC. | $11.70 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Perlman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.